To include your compound in the COVID-19 Resource Center, submit it here.

Senate passes generics bill

In a 94-1 vote, the Senate passed legislation that is intended to make it more difficult for manufacturers of name-brand drugs

Read the full 213 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE